Skip to main navigation Skip to search Skip to main content

Addition of docetaxel to hormonal therapy in low- And high-burden metastatic hormone sensitive prostate cancer: Long-term survival results from the STAMPEDE trial

  • N. W. Clarke*
  • , A. Ali
  • , F. C. Ingleby
  • , A. Hoyle
  • , C. L. Amos
  • , G. Attard
  • , C. D. Brawley
  • , J. Calvert
  • , S. Chowdhury
  • , A. Cook
  • , W. Cross
  • , D. P. Dearnaley
  • , H. Douis
  • , D. Gilbert
  • , S. Gillessen
  • , R. J. Jones
  • , R. E. Langley
  • , A. MacNair
  • , Z. Malik
  • , M. D. Mason
    • D. Matheson, R. Millman, C. C. Parker, A. W.S. Ritchie, H. Rush, J. M. Russell, J. Brown, S. Beesley, A. Birtle, L. Capaldi, J. Gale, S. Gibbs, A. Lydon, A. Nikapota, A. Omlin, J. M. O'Sullivan, O. Parikh, A. Protheroe, S. Rudman, N. N. Srihari, M. Simms, J. S. Tanguay, S. Tolan, J. Wagstaff, J. Wallace, J. Wylie, A. Zarkar, M. R. Sydes, M. K.B. Parmar, N. D. James
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

360 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Addition of docetaxel to hormonal therapy in low- And high-burden metastatic hormone sensitive prostate cancer: Long-term survival results from the STAMPEDE trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry